Catumaxomab monoclonal antibody drug. Targets CD3 and EpCAM. Used in treatment of malignant ascites. Generic name and stylized antibody.


Size: 9000px × 4297px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: adhesion, antibody, ascites, biological, biosimilar, biotech, biotechnology, cancer, catumaxomab, cavity, cd3, cell, disease, drug, epcam, epithelial, fluid, hybrid, immunoglobulin, immunology, infusion, injection, inn, mab, malignant, metastasis, molecule, monoclonal, nomenclature, oncology, peptide, peritoneal, protein, rat-mouse, tumor